IRF8 and COVID-19: Studies show that COVID-19 patients have significantly reduced expression of IRF8, which contributes to the impairment of immune responses mediated by autophagy pathways [89,92,93] and ultimately leads to increased viral proliferation and deregulated inflammatory pathways due to IRF8′s role in MDSC pathology, which is discussed below.